Universal Health Services (UHS)
Universal Health Services on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as services-general medical & surgical hospitals, nec.
2.6M
Short interest
settlement 2026-10-15
4.9
Days to cover
+2.0 days vs prior
75.1%
Short share of volume
2026-10-28
1
Fails to deliver
settlement 2026-09-28
Thu 25 Feb
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in UHS is 2,639,156 shares, down 81,312 shares over the last month. Over the last 48 readings it ranged from 1,234,785 shares (31 October 2024) to 3,400,680 shares (15 July 2026). At the reported average volume of 542K shares a day that is 4.9 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/uhs" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 2,639,156 | +3.2% | 542,251 | 4.87 |
| 2026-09-30 | 2,556,807 | -6.0% | 900,047 | 2.84 |
| 2026-09-15 | 2,720,468 | +5.7% | 654,209 | 4.16 |
| 2026-08-31 | 2,575,023 | +0.4% | 643,501 | 4.00 |
| 2026-08-14 | 2,564,140 | -14.5% | 660,215 | 3.88 |
| 2026-07-31 | 2,999,451 | -11.8% | 1,141,965 | 2.63 |
| 2026-07-15 | 3,400,680 | +12.6% | 900,385 | 3.78 |
| 2026-06-30 | 3,020,568 | +16.7% | 970,591 | 3.11 |
| 2026-06-15 | 2,589,029 | -14.2% | 1,096,698 | 2.36 |
| 2026-05-29 | 3,017,021 | -0.6% | 1,363,069 | 2.21 |
| 2026-05-15 | 3,035,724 | +8.3% | 1,046,435 | 2.90 |
| 2026-04-30 | 2,802,274 | +34.3% | 870,005 | 3.22 |
| 2026-04-15 | 2,086,733 | -1.4% | 555,078 | 3.76 |
| 2026-03-31 | 2,115,498 | +19.1% | 746,015 | 2.84 |
| 2026-03-13 | 1,776,277 | -12.1% | 875,041 | 2.03 |
| 2026-02-27 | 2,020,975 | +4.6% | 908,705 | 2.22 |
| 2026-02-13 | 1,932,160 | -4.1% | 720,799 | 2.68 |
| 2026-01-30 | 2,014,107 | +0.8% | 625,428 | 3.22 |
| 2026-01-15 | 1,997,759 | -3.2% | 834,342 | 2.39 |
| 2025-12-31 | 2,063,392 | +0.1% | 721,137 | 2.86 |
| 2025-12-15 | 2,061,590 | +10.6% | 719,477 | 2.87 |
| 2025-11-28 | 1,863,811 | -0.8% | 720,671 | 2.59 |
| 2025-11-14 | 1,879,417 | +2.6% | 609,369 | 3.08 |
| 2025-10-31 | 1,831,780 | -2.5% | 657,061 | 2.79 |
| 2025-10-15 | 1,878,407 | -14.5% | 568,352 | 3.31 |
| 2025-09-30 | 2,196,728 | -10.7% | 721,365 | 3.05 |
| 2025-09-15 | 2,458,813 | +2.6% | 670,661 | 3.67 |
| 2025-08-29 | 2,396,638 | +10.9% | 748,751 | 3.20 |
| 2025-08-15 | 2,160,316 | +3.4% | 768,762 | 2.81 |
| 2025-07-31 | 2,090,171 | -3.6% | 1,283,775 | 1.63 |
| 2025-07-15 | 2,169,125 | -0.7% | 722,466 | 3.00 |
| 2025-06-30 | 2,183,958 | +0.3% | 1,189,619 | 1.84 |
| 2025-06-13 | 2,177,443 | +1.3% | 763,955 | 2.85 |
| 2025-05-30 | 2,149,144 | -14.0% | 601,696 | 3.57 |
| 2025-05-15 | 2,498,790 | -1.4% | 831,260 | 3.01 |
| 2025-04-30 | 2,534,690 | +2.4% | 959,925 | 2.64 |
| 2025-04-15 | 2,474,385 | -7.6% | 808,103 | 3.06 |
| 2025-03-31 | 2,677,431 | -4.2% | 963,718 | 2.78 |
| 2025-03-14 | 2,793,309 | +43.3% | 1,200,862 | 2.33 |
| 2025-02-28 | 1,949,222 | +10.8% | 1,106,585 | 1.76 |
| 2025-02-14 | 1,759,722 | -1.4% | 532,479 | 3.30 |
| 2025-01-31 | 1,785,571 | +3.7% | 446,115 | 4.00 |
| 2025-01-15 | 1,721,400 | -5.2% | 515,099 | 3.34 |
| 2024-12-31 | 1,815,948 | -5.2% | 636,240 | 2.85 |
| 2024-12-13 | 1,914,514 | +25.4% | 518,261 | 3.69 |
| 2024-11-29 | 1,526,810 | -0.2% | 824,235 | 1.85 |
| 2024-11-15 | 1,530,379 | +23.9% | 756,713 | 2.02 |
| 2024-10-31 | 1,234,785 | -19.2% | 904,227 | 1.37 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of UHS volume is 75.1%, up 29.4 points over the last five sessions. Over the last 30 readings it ranged from 45.7% (21 October 2026) to 89.5% (29 September 2026). The latest reading is 4.4 points above the 30-session average of 70.7%, on 716K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 538K | 716K | 75.1% | 0 |
| 2026-10-27 | 356K | 506K | 70.3% | 0 |
| 2026-10-26 | 195K | 289K | 67.4% | 0 |
| 2026-10-23 | 95K | 157K | 60.6% | 744 |
| 2026-10-22 | 107K | 191K | 56.1% | 201 |
| 2026-10-21 | 66K | 144K | 45.7% | 0 |
| 2026-10-20 | 61K | 122K | 50.5% | 443 |
| 2026-10-19 | 110K | 164K | 67.3% | 0 |
| 2026-10-16 | 118K | 167K | 70.3% | 0 |
| 2026-10-15 | 101K | 161K | 62.8% | 110 |
| 2026-10-14 | 172K | 249K | 69.0% | 308 |
| 2026-10-13 | 133K | 215K | 61.7% | 12 |
| 2026-10-12 | 110K | 167K | 65.7% | 10 |
| 2026-10-09 | 92K | 128K | 72.1% | 0 |
| 2026-10-08 | 107K | 140K | 76.9% | 31 |
| 2026-10-07 | 138K | 189K | 72.8% | 1,204 |
| 2026-10-06 | 104K | 136K | 76.3% | 2 |
| 2026-10-05 | 102K | 178K | 57.2% | 0 |
| 2026-10-02 | 150K | 188K | 79.9% | 0 |
| 2026-10-01 | 187K | 222K | 84.4% | 13 |
| 2026-09-30 | 185K | 215K | 86.0% | 0 |
| 2026-09-29 | 176K | 197K | 89.5% | 1 |
| 2026-09-28 | 182K | 257K | 70.6% | 0 |
| 2026-09-25 | 225K | 268K | 83.9% | 5 |
| 2026-09-24 | 187K | 277K | 67.6% | 449 |
| 2026-09-23 | 270K | 322K | 83.9% | 67 |
| 2026-09-22 | 167K | 253K | 65.8% | 31 |
| 2026-09-21 | 227K | 295K | 76.7% | 22 |
| 2026-09-18 | 204K | 261K | 77.9% | 3 |
| 2026-09-17 | 274K | 360K | 76.1% | 472 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 28 September 2026, the fails-to-deliver balance in UHS is 1 share, down 30 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (28 September 2026) to 45,679 shares (11 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-28 | 1 | $178.86 | $179 |
| 2026-09-22 | 31 | $174.74 | $5K |
| 2026-09-16 | 14,231 | $176.85 | $2.5M |
| 2026-08-31 | 2,275 | $171.66 | $391K |
| 2026-08-27 | 2 | $178.69 | $357 |
| 2026-08-24 | 4,456 | $177.26 | $790K |
| 2026-08-18 | 4 | $170.53 | $682 |
| 2026-08-11 | 45,679 | $172.74 | $7.9M |
| 2026-08-05 | 30,124 | $167.87 | $5.1M |
| 2026-08-04 | 19,148 | $169.04 | $3.2M |
| 2026-07-31 | 4 | $163.29 | $653 |
| 2026-07-30 | 40 | $168.16 | $7K |
| 2026-07-20 | 436 | $151.16 | $66K |
| 2026-07-17 | 110 | $153.54 | $17K |
| 2026-07-14 | 4,512 | $152.77 | $689K |
| 2026-07-09 | 2,237 | $156.43 | $350K |
| 2026-07-08 | 89 | $161.26 | $14K |
| 2026-07-06 | 346 | $158.33 | $55K |
| 2026-06-30 | 25,746 | $147.02 | $3.8M |
| 2026-06-22 | 1,094 | $141.17 | $154K |
| 2026-06-18 | 1,121 | $141.26 | $158K |
| 2026-06-17 | 186 | $146.90 | $27K |
| 2026-06-15 | 28,109 | $146.42 | $4.1M |
| 2026-06-11 | 1,607 | $144.82 | $233K |
| 2026-06-09 | 36,204 | $142.87 | $5.2M |
| 2026-06-04 | 44 | $145.98 | $6K |
| 2026-05-19 | 26,016 | $169.27 | $4.4M |
| 2026-05-18 | 5,701 | $168.64 | $961K |
| 2026-05-14 | 3 | $171.01 | $513 |
| 2026-04-24 | 13,020 | $181.18 | $2.4M |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for UHS in the last 90 days. The most recent filings are listed below. Latest filing: MILLER ALAN B (Executive Chairman) on 2026-05-27.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 25K | $0.00 | $0 | 25K |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 25K | $0.00 | $0 | 1.8M |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 25K | $0.00 | $0 | 25K |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 51K | $0.00 | $0 | 51K |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 14K | $0.00 | $0 | 1.9M |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 14K | $0.00 | $0 | 10K |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 14K | $0.00 | $0 | 1.9M |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 14K | $0.00 | $0 | 10K |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 14K | $0.00 | $0 | 1.8M |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 9K | $0.00 | $0 | 1.8M |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 9K | $0.00 | $0 | 0 |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 9K | $0.00 | $0 | 1.8M |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 14K | $0.00 | $0 | 1.8M |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 25K | $0.00 | $0 | 1.8M |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 51K | $0.00 | $0 | 1.8M |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 14K | $0.00 | $0 | 10K |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 9K | $0.00 | $0 | 0 |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | Other transaction | 14K | $0.00 | $0 | 0 |
| 2026-05-20 | Singer Maria Ruderman | Director | Grant | 1K | $0.00 | $0 | 10K |
| 2026-05-20 | SUSSMAN ELLIOT J MD MBA | Director | Grant | 1K | $0.00 | $0 | 7K |
| 2026-05-20 | Nimetz Warren J. | Director | Grant | 1K | $0.00 | $0 | 10K |
| 2026-05-20 | McDonnell Eileen C. | Director | Grant | 1K | $0.00 | $0 | 9K |
| 2026-05-20 | Chen-Langenmayr Nina | Director | Grant | 1K | $0.00 | $0 | 4K |
| 2026-03-26 | Sim Edward H | Executive Vice President | Grant | 6K | $0.00 | $0 | 25K |
| 2026-03-26 | Peterson Matthew Jay | Executive Vice President, UHS | Grant | 6K | $0.00 | $0 | 32K |
| 2026-03-26 | Miller Marc D | President and CEO | Grant | 30K | $0.00 | $0 | 389K |
| 2026-03-26 | MILLER ALAN B | Executive Chairman | Grant | 14K | $0.00 | $0 | 1.8M |
| 2026-03-26 | FILTON STEVE | Executive Vice President & CFO | Grant | 7K | $0.00 | $0 | 145K |
| 2026-03-21 | Sim Edward H | Executive Vice President | Tax withholding | 593 | $185.82 | $110K | 18K |
| 2026-03-21 | Peterson Matthew Jay | Executive Vice President, UHS | Tax withholding | 512 | $185.82 | $95K | 26K |
| 2026-03-21 | Miller Marc D | President and CEO | Tax withholding | 2K | $185.82 | $416K | 359K |
| 2026-03-21 | MILLER ALAN B | Executive Chairman | Tax withholding | 1K | $185.82 | $219K | 1.8M |
| 2026-03-21 | FILTON STEVE | Executive Vice President & CFO | Tax withholding | 616 | $185.82 | $114K | 138K |
| 2026-03-19 | Sim Edward H | Executive Vice President | Tax withholding | 704 | $189.58 | $133K | 19K |
| 2026-03-19 | Peterson Matthew Jay | Executive Vice President, UHS | Tax withholding | 608 | $189.58 | $115K | 27K |
| 2026-03-19 | Miller Marc D | President and CEO | Tax withholding | 3K | $189.58 | $524K | 361K |
| 2026-03-19 | MILLER ALAN B | Executive Chairman | Tax withholding | 1K | $189.58 | $265K | 1.8M |
| 2026-03-19 | FILTON STEVE | Executive Vice President & CFO | Tax withholding | 731 | $189.58 | $139K | 138K |
| 2026-03-13 | SUSSMAN ELLIOT J MD MBA | Director | Sell | 356 | $193.37 | $69K | 6K |
| 2026-03-13 | SUSSMAN ELLIOT J MD MBA | Director | Tax withholding | 894 | $194.27 | $174K | 6K |
| 2026-03-13 | SUSSMAN ELLIOT J MD MBA | Director | Exercise or conversion | 1K | $138.80 | $174K | 7K |
| 2026-03-12 | Singer Maria Ruderman | Director | Tax withholding | 2K | $191.88 | $347K | 9K |
| 2026-03-12 | Singer Maria Ruderman | Director | Exercise or conversion | 3K | $138.80 | $347K | 10K |
| 2026-03-12 | Sim Edward H | Executive Vice President | Tax withholding | 7K | $190.49 | $1.3M | 20K |
| 2026-03-12 | Sim Edward H | Executive Vice President | Grant | 15K | $0.00 | $0 | 26K |
| 2026-03-12 | Peterson Matthew Jay | Executive Vice President, UHS | Tax withholding | 6K | $190.49 | $1.1M | 27K |
| 2026-03-12 | Peterson Matthew Jay | Executive Vice President, UHS | Grant | 13K | $0.00 | $0 | 33K |
| 2026-03-12 | Miller Marc D | President and CEO | Tax withholding | 25K | $190.49 | $4.7M | 364K |
| 2026-03-12 | Miller Marc D | President and CEO | Grant | 63K | $0.00 | $0 | 389K |
| 2026-03-12 | Miller Marc D | President and CEO | Tax withholding | 86K | $190.82 | $16.4M | 326K |
| 2026-03-12 | Miller Marc D | President and CEO | Exercise or conversion | 50K | $152.68 | $7.7M | 412K |
| 2026-03-12 | Miller Marc D | President and CEO | Exercise or conversion | 50K | $138.80 | $6.9M | 361K |
| 2026-03-12 | MILLER ALAN B | Executive Chairman | Tax withholding | 13K | $190.49 | $2.5M | 1.8M |
| 2026-03-12 | MILLER ALAN B | Executive Chairman | Grant | 33K | $0.00 | $0 | 1.8M |
| 2026-03-12 | FILTON STEVE | Executive Vice President & CFO | Tax withholding | 7K | $190.49 | $1.3M | 139K |
| 2026-03-12 | FILTON STEVE | Executive Vice President & CFO | Grant | 16K | $0.00 | $0 | 146K |
| 2026-03-12 | FILTON STEVE | Executive Vice President & CFO | Tax withholding | 72K | $192.28 | $13.8M | 130K |
| 2026-03-12 | FILTON STEVE | Executive Vice President & CFO | Exercise or conversion | 44K | $152.68 | $6.7M | 202K |
| 2026-03-12 | FILTON STEVE | Executive Vice President & CFO | Exercise or conversion | 39K | $138.80 | $5.4M | 158K |
| 2026-03-11 | SUSSMAN ELLIOT J MD MBA | Director | Sell | 318 | $186.35 | $59K | 6K |
| 2026-03-11 | SUSSMAN ELLIOT J MD MBA | Director | Tax withholding | 932 | $186.28 | $174K | 6K |
| 2026-03-11 | SUSSMAN ELLIOT J MD MBA | Director | Exercise or conversion | 1K | $138.80 | $174K | 7K |
| 2026-03-10 | MILLER ALAN B | Executive Chairman | Tax withholding | 114K | $189.62 | $21.7M | 1.8M |
| 2026-03-10 | MILLER ALAN B | Executive Chairman | Exercise or conversion | 70K | $152.68 | $10.7M | 1.9M |
| 2026-03-10 | MILLER ALAN B | Executive Chairman | Exercise or conversion | 63K | $138.80 | $8.7M | 1.8M |
| 2025-11-11 | Nimetz Warren J. | Director | Sell | 142 | $223.96 | $32K | 8K |
| 2025-11-11 | Nimetz Warren J. | Director | Sell | 4K | $223.28 | $821K | 9K |
| 2025-11-11 | Nimetz Warren J. | Director | Tax withholding | 6K | $224.49 | $1.4M | 12K |
| 2025-11-11 | Nimetz Warren J. | Director | Exercise or conversion | 10K | $138.80 | $1.4M | 18K |
| 2025-10-29 | SUSSMAN ELLIOT J MD MBA | Director | Sell | 965 | $225.70 | $218K | 6K |
| 2025-10-29 | SUSSMAN ELLIOT J MD MBA | Director | Tax withholding | 2K | $226.15 | $347K | 7K |
| 2025-10-29 | SUSSMAN ELLIOT J MD MBA | Director | Exercise or conversion | 3K | $138.80 | $347K | 9K |
| 2025-10-29 | Peterson Matthew Jay | Executive Vice President, UHS | Tax withholding | 14K | $225.15 | $3.2M | 20K |
| 2025-10-29 | Peterson Matthew Jay | Executive Vice President, UHS | Exercise or conversion | 9K | $152.68 | $1.4M | 34K |
| 2025-10-29 | Peterson Matthew Jay | Executive Vice President, UHS | Exercise or conversion | 8K | $138.80 | $1.2M | 25K |
| 2025-10-29 | Miller Marc D | President and CEO | Tax withholding | 132K | $225.30 | $29.7M | 311K |
| 2025-10-29 | Miller Marc D | President and CEO | Exercise or conversion | 90K | $152.68 | $13.7M | 443K |
| 2025-10-29 | Miller Marc D | President and CEO | Exercise or conversion | 75K | $138.80 | $10.4M | 353K |
| 2025-10-29 | MILLER ALAN B | Executive Chairman | Tax withholding | 106K | $227.04 | $24.0M | 1.7M |
| 2025-10-29 | MILLER ALAN B | Executive Chairman | Exercise or conversion | 63K | $138.80 | $8.7M | 1.9M |
| 2025-10-29 | MILLER ALAN B | Executive Chairman | Exercise or conversion | 70K | $152.68 | $10.7M | 1.8M |
| 2025-08-06 | MILLER ALAN B | Executive Chairman | Other transaction | 83K | $0.00 | $0 | 1.7M |
| 2025-08-06 | MILLER ALAN B | Executive Chairman | Other transaction | 83K | $0.00 | $0 | 1.6M |
| 2025-08-06 | MILLER ALAN B | Executive Chairman | Other transaction | 17K | $0.00 | $0 | 0 |
| 2025-08-06 | MILLER ALAN B | Executive Chairman | Other transaction | 83K | $0.00 | $0 | 0 |
| 2025-08-06 | MILLER ALAN B | Executive Chairman | Other transaction | 176K | $0.00 | $0 | 1.6M |
| 2025-08-06 | Miller Marc D | President and CEO | Other transaction | 17K | $0.00 | $0 | 49K |
| 2025-08-06 | Miller Marc D | President and CEO | Other transaction | 17K | $0.00 | $0 | 0 |
| 2025-08-06 | Miller Marc D | President and CEO | Other transaction | 17K | $0.00 | $0 | 70K |
| 2025-08-06 | Miller Marc D | President and CEO | Other transaction | 83K | $0.00 | $0 | 0 |
| 2025-08-06 | Miller Marc D | President and CEO | Other transaction | 24K | $0.00 | $0 | 37K |
| 2025-08-06 | Miller Marc D | President and CEO | Other transaction | 17K | $0.00 | $0 | 0 |
| 2025-08-06 | Miller Marc D | President and CEO | Other transaction | 24K | $0.00 | $0 | 0 |
| 2025-08-06 | Miller Marc D | President and CEO | Other transaction | 176K | $0.00 | $0 | 0 |
| 2025-08-06 | Miller Marc D | President and CEO | Other transaction | 83K | $0.00 | $0 | 0 |
| 2025-08-06 | MILLER ALAN B | Executive Chairman | Other transaction | 17K | $0.00 | $0 | 0 |
| 2025-08-06 | MILLER ALAN B | Executive Chairman | Other transaction | 83K | $0.00 | $0 | 0 |
| 2025-08-06 | MILLER ALAN B | Executive Chairman | Other transaction | 24K | $0.00 | $0 | 0 |
| 2025-08-06 | MILLER ALAN B | Executive Chairman | Other transaction | 176K | $0.00 | $0 | 0 |
| 2025-05-22 | MILLER ALAN B | Executive Chairman | Other transaction | 24K | $0.00 | $0 | 24K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON4 Form 144 notices on file for UHS worth $1.2M at the prices reported; 0 in the last 90 days worth $0. Latest: ELLIOT SUSSMAN filed on 2026-03-13 to sell 356 shares ($69K) from 2026-03-13.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-03-13 | ELLIOT SUSSMANDirector | 356 | $69K | 0.001% | 2026-03-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-11 | ELLIOT SUSSMANDirector | 318 | $59K | 0.001% | 2026-03-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | WARREN NIMETZDirector | 4K | $852K | 0.058% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-29 | ELLIOT SUSSMANDirector | 965 | $218K | 0.002% | 2025-10-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON5 holders report 5% or more of UHS in their latest filing, all on Schedule 13G (passive). The largest reported stake is First Eagle Investment Management, LLC at 8.8% of the class (4,674,801 shares), filed 2026-08-06 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-19 | 13G | PZENA INVESTMENT MANAGEMENT LLCinvestment adviser | 2.6M | 5.1% | 2026-09-30 |
| 2026-10-08 | 13G | Dimensional Fund Advisors LPinvestment adviser | 2.7M | 5.2% | 2026-09-30 |
| 2026-08-06 | 13G/Ano. 2 | First Eagle Investment Management, LLCinvestment adviser | 4.7M | 8.8% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 2 | FIRST EAGLE GLOBAL FUNDinsurance company | 3.1M | 5.8% | 2026-06-30 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 3.9M | 7.3% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 12 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding UHS at their latest 13F. JSON6 of the 30 tracked managers held UHS at their latest 13F, $246.4M in total at quarter-end prices. AQR Capital Management is the largest at $76.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 523K | $76.9M | 0.03% | -62K |
| Millennium Management | 2026-06-30 | 417K | $62.1M | 0.02% | -270K |
| Citadel Advisors | 2026-06-30 | 308K | $45.8M | 0.01% | +226K |
| Bridgewater Associates | 2026-06-30 | 228K | $33.9M | 0.14% | +92K |
| D. E. Shaw & Co. | 2026-06-30 | 145K | $21.6M | 0.01% | +41K |
| Point72 Asset Management | 2026-06-30 | 41K | $6.2M | 0.01% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Universal Health Services reported revenue of $4.64B, up 8.3% from the same quarter a year earlier, and net income of $358.4M (5.98 diluted EPS). In FY 2025 it generated $1.86B of operating cash flow and spent $968.0M on buybacks and $51.3M on dividends. As of 2026-06-30, cash was $138.8M against $4.90B of debt.
- Cash
- $138.8M
- Debt
- $4.90B
- Equity
- $7.51B
- Total assets
- $15.94B
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $4.64B | $358.4M | 7.7% | 5.98 |
| Q1 FY 2026 | 2026-03-31 | $4.50B | $348.7M | 7.8% | 5.65 |
| Q4 FY 2025derived | 2025-12-31 | $4.49B | $445.9M | 9.9% | n/a |
| Q3 FY 2025 | 2025-09-30 | $4.50B | $373.0M | 8.3% | 5.86 |
| Q2 FY 2025 | 2025-06-30 | $4.28B | $353.2M | 8.2% | 5.43 |
| Q1 FY 2025 | 2025-03-31 | $4.10B | $316.7M | 7.7% | 4.80 |
| Q4 FY 2024derived | 2024-12-31 | $4.11B | $332.4M | 8.1% | n/a |
| Q3 FY 2024 | 2024-09-30 | $3.96B | $258.7M | 6.5% | 3.80 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $17.36B | $1.49B | $1.86B | $1.02B | $968.0M | $51.3M |
| FY 2024 | 2024-12-31 | $15.83B | $1.14B | $2.07B | $943.8M | $670.8M | $53.3M |
| FY 2023 | 2023-12-31 | $14.28B | $717.8M | $1.27B | $743.1M | $547.4M | $55.5M |
| FY 2022 | 2022-12-31 | $13.40B | $675.6M | $996.0M | $734.0M | $832.9M | $58.4M |
| FY 2021 | 2021-12-31 | $12.64B | $991.6M | $883.7M | $855.7M | $1.22B | $65.9M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30.
What this page is
Universal Health Services in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Universal Health Services (UHS), SEC CIK 352915, listed on NYSE, classified by the SEC as services-general medical & surgical hospitals, nec. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-28.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-03-13.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-19.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-10-27.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-05-27.JSON and CSV
- Company record
- EDGAR filing index for CIK 352915Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-general medical & surgical hospitals, nec
Other company pages
- JCIJohnson Controls International
- JDJD.com
- JEFJefferies Financial Group
- JHXJames Hardie Industries
- JKHYJack Henry & Associates
- JLLJones Lang Lasalle
- JNJJohnson & Johnson
- JOBYJoby Aviation
- JPMJPMorgan Chase
- JXNJackson Financial
- KDPKeurig Dr Pepper
- KEYKeyCorp
- KEYSKeysight Technologies
- KGCKinross Gold
- KHCKraft Heinz
- KIMKimco Realty
- KKRKKR
- KLACKLA
- KMBKimberly-Clark
Datasets
Frequently Asked Questions
How much of UHS is sold short?
2,639,156 shares were held short at the 2026-10-15 settlement, 4.9 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is UHS's daily short volume?
On 2026-10-28, 537,538 of the 715,678 UHS shares reported to FINRA were sold short, 75.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does UHS have fails to deliver?
The SEC's latest file shows 1 UHS shares failed to deliver at settlement 2026-09-28. Fails are reported per settlement date and published twice a month with a lag.
Are UHS insiders buying or selling?
No open-market insider trades were reported for UHS in the last 90 days. The most recent filings are listed below. Latest filing: MILLER ALAN B (Executive Chairman) on 2026-05-27.
Have UHS insiders filed to sell?
4 Form 144 notices on file for UHS worth $1.2M at the prices reported; 0 in the last 90 days worth $0. Latest: ELLIOT SUSSMAN filed on 2026-03-13 to sell 356 shares ($69K) from 2026-03-13.
Who owns 5% or more of UHS?
5 holders report 5% or more of UHS in their latest filing, all on Schedule 13G (passive). The largest reported stake is First Eagle Investment Management, LLC at 8.8% of the class (4,674,801 shares), filed 2026-08-06 for an event on 2026-06-30.
What did UHS report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Universal Health Services reported revenue of $4.64B, up 8.3% from the same quarter a year earlier, and net income of $358.4M (5.98 diluted EPS). In FY 2025 it generated $1.86B of operating cash flow and spent $968.0M on buybacks and $51.3M on dividends. As of 2026-06-30, cash was $138.8M against $4.90B of debt.
Which tracked 13F managers own UHS?
6 of the 30 tracked 13F managers held UHS shares at their latest filing, $246.4M in all. The largest: Cliff Asness's AQR Capital Management (523K shares, $76.9M), Izzy Englander's Millennium Management (417K shares, $62.1M), Ken Griffin's Citadel Advisors (308K shares, $45.8M), Ray Dalio's Bridgewater Associates (228K shares, $33.9M), D. E. Shaw & Co. (145K shares, $21.6M), Steve Cohen's Point72 Asset Management (41K shares, $6.2M).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.